- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04888923
Natural History of the Human Biological Response to Environmental Exposure and Injury
Background:
Environmental exposures like pollution, diet, and stress can help cause human diseases, or make them worse. Researchers want to better understand how injury and inflammation are caused by these exposures. They want to collect biological and environmental samples and other data. They may use the samples to measure a range of factors, like hormones, toxins, and chemicals. This will help them improve their studies.
Objective:
To identify and understand how environmental exposures contribute to human disease.
Eligibility:
Healthy adults ages 18 and older
Design:
Participants will be screened with questions about their health history, demographics, and medicines they take.
Participants may give blood, hair, stool, saliva, and/or urine samples. They may have a skin punch biopsy to collect skin cells. They may give fingernail or toenail clippings. They may give a sample of exhaled breath.
Participants may give a sputum sample. They will inhale a saline mist and cough mucus into a cup.
Participants may have their nasal passages brushed, scraped, or washed.
Participants may give cheek cell samples. They will swish mouthwash and spit it into a cup.
Participants who produce sperm may give samples.
Participants may have bronchoscopy to collect fluid. A saline solution will be put into their lung and then suctioned out, washing areas of the lung.
Participants may have a pelvic or transvaginal ultrasound. They may have lung function tests.
Participants may collect household dust, urine, or stool at home.
Participants will complete surveys about their health, diet, and exposures.
Participation will last for one or more study visits.
Participants may be contacted in the future to take part in other studies.
Studieoversikt
Status
Detaljert beskrivelse
Study Description:
Environmental exposures such as pollution, diet, stress, etc. contribute to the development and exacerbation of human disease. Understanding the mechanisms of environmentally induced injury and inflammation will allow us to devise better prophylaxis and treatment measures.
Subjects may undergo sampling of (including but not limited to:) blood, urine, saliva, household dust, cheek cells, hair, nasal cells, stool, nail clippings, exhaled breath condensate, sperm samples, skin cells, and/or sputum etc., and may answer predefined questionnaires regarding health and exposures.
Studies which may be performed on collected material includes establishment of cell cultures and immunologic studies.
Objectives:
Primary Objective: To identify the interaction of host and environmental factors in the response to injury and the development of disease.
Secondary Objectives: To develop better methodological tools in order to quantify host-environmental interactions in health and disease.
Endpoints:
Primary Endpoint: Biological markers of cell/tissue injury and inflammation, such as inflammatory cytokines, intracellular kinases or DNA/RNA damage in association with in vitro or in vivo environmental exposures.
Secondary Endpoints: Diseases or pathological processes (e.g. abnormal laboratory values) associated with environmental exposures.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: NIEHS Join A Study Recruitment Group
- Telefonnummer: (855) 696-4347
- E-post: myniehs@nih.gov
Studer Kontakt Backup
- Navn: Lawrence S Kirschner, M.D.
- Telefonnummer: (984) 287-3562
- E-post: lawrence.kirschner@nih.gov
Studiesteder
-
-
North Carolina
-
Research Triangle Park, North Carolina, Forente stater, 27709
- Rekruttering
- NIEHS Clinical Research Unit (CRU)
-
Ta kontakt med:
- NIEHS Join A Study Recruitment Group
- Telefonnummer: 855-696-4347
- E-post: myniehs@nih.gov
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
The general community sample will be from Durham, Raleigh, Chapel Hill and other nearby cities close to the NIEHS Clinical Research Unit (CRU).
Beskrivelse
- INCLUSION CRITERIA:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Stated willingness to comply with all study procedures and availability for the duration of the study.
- Ability to provide informed consent.
- Able to read and speak English
- Male or female, aged >=18
- Able to travel to the NIEHS CRU for study visits or travel to an offsite event or conference.
EXCLUSION CRITERIA:
An individual who meets any of the following criteria will be excluded from participation in this study:
- Not willing to have samples stored for future use.
- Current pregnancy or lactation, by participant verbal confirmation.
- Any condition that, in the investigator's opinion, places the participant at undue risk for complications associated with required study procedures.
Participants will be enrolled according to pre-defined host (e.g. disease, genetic, or demographic) or environmental (exposure) characteristics.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: OTHER
- Tidsperspektiver: PROSPECTIVE
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Healthy Controls
General public population, including females and males, who are over the age of 18, with a mixture of races and ethnicities representative of North Carolina. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
To identify the interaction of host and environmental factors in the response to injury and the development of disease.
Tidsramme: On-going
|
To identify the interaction of host and environmental factors in the response to injury and the development of disease. |
On-going
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Lawrence S Kirschner, M.D., National Institute of Environmental Health Sciences (NIEHS)
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 10000152
- 000152-E
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Most of the participant data will be utilized by investigators in an aggregate way to validate or invalidate their research.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .